CF Industries Holdings (CF) has come under closer scrutiny after being dropped from the FTSE All-World Index, alongside sizeable insider sales and mixed analyst commentary that have all fed into recent share price swings.
See our latest analysis for CF Industries Holdings.
The recent drop from the FTSE All-World Index, sizeable insider sales and mixed analyst views have not stopped CF Industries’ strong run. A 30 day share price return of 22.7% and a 1 year total shareholder return of 64.0% point to momentum that has built rather than faded.
If CF’s swings around index changes and insider moves have your attention, it can be useful to see what else is moving in related areas, including 94 nuclear energy infrastructure stocks
With CF trading above some analyst targets but sitting on an estimated 20.5% intrinsic discount, the real question for you is simple: is there still value left to capture here, or is the market already pricing in future growth?
CF Industries last closed at $127.98, while the most followed narrative pegs fair value closer to $105.63. This creates a clear gap between price and implied worth.
The tight global nitrogen supply demand balance, currently driven by chronic supply side constraints and geopolitical disruptions, is at risk as new capacity from China and other regions and policy changes could lead to overcapacity, putting downward pressure on nitrogen pricing, revenue, and net margins in the coming years.
Want to understand what is really behind that valuation gap? The narrative focuses on shifting revenues, thinner margins, and a different future earnings profile. Curious which assumptions move the fair value most.
Result: Fair Value of $105.63 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, stronger long term fertilizer demand and CF’s early move into low carbon ammonia could challenge the idea that the current level of earnings power is overstated.
Find out about the key risks to this CF Industries Holdings narrative.
The narrative based on analyst targets flags CF as about 21% overvalued at $127.98 versus a fair value of $105.63. Yet on simple P/E numbers, CF trades at 13.5x earnings versus a fair ratio of 18x, and around 28.9x for both the US Chemicals industry and peers. That kind of discount can point to either a margin of safety or the market pricing in real risks. Which side do you think is closer to the truth?
See what the numbers say about this price — find out in our valuation breakdown.
With sentiment clearly split between risks and rewards, it helps to move fast and check the details yourself so your view is grounded. You can start with the 4 key rewards and 2 important warning signs.
If CF no longer looks like the only opportunity on your radar, now is the time to widen your watchlist and let the data work for you.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English